Statistics for E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer
Total visits
| views | |
|---|---|
| E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer | 2 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:cccca654-dd52-4ff7-b76e-9e4450821186 | 26 |
| java.util.UUID:ccff6abf-52bb-431d-ab81-c6fa676bc8cd | 12 |
| Yeruva2018Randomized-CCBY.pdf | 6 |
| java.util.UUID:ed3305d6-d737-4d05-9997-390b409ff045 | 6 |
Top country views
| views | |
|---|---|
| United States | 2 |
Top city views
| views | |
|---|---|
| Indianapolis | 2 |